Jul 01, 2024 8:00am EDT Achieve Life Sciences Announces Addition to the U.S. Russell 3000® and Russell Microcap® Indexes
May 29, 2024 8:00am EDT Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes
May 17, 2024 8:00am EDT Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting
May 09, 2024 4:01pm EDT Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update
May 06, 2024 11:16am EDT Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine
Apr 25, 2024 8:00am EDT Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024
Apr 11, 2024 8:00am EDT Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference
Mar 28, 2024 4:01pm EDT Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update
Mar 20, 2024 8:00am EDT Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
Mar 14, 2024 8:00am EDT Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024